Filing Details
- Accession Number:
- 0000950170-23-012066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-06 16:06:27
- Reporting Period:
- 2023-04-04
- Accepted Time:
- 2023-04-06 16:06:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1785173 | 89Bio Inc. | ETNB | Pharmaceutical Preparations (2834) | 831114349 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792018 | Ryan Martins | C/O 89Bio, Inc. 142 Sansome Street, 2Nd Floor San Francisco CA 94104 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-04-04 | 8,721 | $14.95 | 53,578 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022 in multiple trades at prices ranging from $14.81 to $15.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
